Target Name: BACH1
NCBI ID: G571
Other Name(s): Basic region leucine zipper transcriptional regulator BACH1 | BACH-1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1, transcript variant 2 | BTBD24 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | BTB and CNC homolog 1 | BTB domain and CNC homolog 1, transcript variant 1 | BACH1_HUMAN | Transcription regulator protein BACH1 | BACH1 variant 1 | basic region leucine zipper transcriptional regulator BACH1 | BTB domain and CNC homolog 1 | HA2303 | BACH1 variant 2

Unlocking the Potential of BACH1: A Drug Target and Biomarker for Leucine Zipper Transcriptional Regulator

Leucine zipper transcriptional regulator (LZTR) is a non-coding RNA molecule that plays a crucial role in regulating gene expression and is implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. BACH1, the Basic Region Leucine Zipper Transcriptional Regulator, is a key player in the regulation of LZTR and has been identified as a potential drug target and biomarker. In this article, we will explore the structure, function, and potential therapeutic applications of BACH1.

Structure and Function

BACH1 is a non-coding RNA molecule that contains 295 amino acid residues and has a unique open-loop structure with a single exon and a single intron. It is characterized by the presence of a Leucine Zipper (LZ) domain, which is a well- conserved regions that are involved in the regulation of gene expression. The LZ domain is responsible for the formation of a zipper-like structure that interacts with the adjacent DNA and RNA.

BACH1 is primarily expressed in the brain and is known to play a role in the regulation of neuronal differentiation, synaptic plasticity, and neurotransmitter release. It has also been shown to be involved in the regulation of sleep-wake cycles, which is critical for maintaining brain function and quality of life.

In addition to its role in neural development and function, BACH1 is also a potential drug target. Leucine zippers are often targeted by small molecules, including inhibitors, to modulate gene expression and regulate cellular processes. BACH1 has been shown to be sensitive to such inhibitors, which suggests that it may be an attractive target for drug development.

BACKGROUND

The regulation of gene expression is a critical process that enables the cell to maintain homeostasis and achieve specific goals, including cell growth, differentiation, and survival. Leucine zipper transcriptional regulators (LZTRs) are a subclass of non-coding RNAs that play a crucial role in regulating gene expression by binding to specific DNA sequences.

BACKGROUND

Leucine zipper transcriptional regulators (LZTRs) are a subclass of non-coding RNAs that play a crucial role in regulating gene expression by binding to specific DNA sequences.

BACKGROUND

BACH1 is a key player in the regulation of LZTR and has been shown to play a role in the regulation of neuronal differentiation, synaptic plasticity, and neurotransmitter release.

Potential Therapeutic Applications

BACH1 is a potential drug target due to its involvement in the regulation of gene expression and its sensitivity to small molecules that target the LZ domain. In addition to its potential as a drug target, BACH1 has also been identified as a potential biomarker for various neurological and psychiatric diseases.

Potential therapeutic applications of BACH1 include the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. These conditions are characterized by the progressive loss of brain cells and the disruption of normal cellular processes.

In addition to its potential therapeutic applications, BACH1 has also been shown to be involved in the regulation of sleep-wake cycles, which is critical for maintaining brain function and quality of life. Therefore, BACH1 may also be a potential target for the treatment of insomnia and other sleep disorders.

Conclusion

In conclusion, BACH1 is a non-coding RNA molecule that plays a crucial role in regulating gene expression and has been shown to be involved in the regulation of neuronal differentiation, synaptic plasticity, and neurotransmitter release. Its unique open-loop structure and conservation in the LZ domain make it a potential drug target and biomarker for various neurological and psychiatric diseases. Further research is needed to fully understand the role of BACH1 in

Protein Name: BTB Domain And CNC Homolog 1

Functions: Transcriptional regulator that acts as repressor or activator, depending on the context. Binds to NF-E2 DNA binding sites. Plays important roles in coordinating transcription activation and repression by MAFK (By similarity). Together with MAF, represses the transcription of genes under the control of the NFE2L2 oxidative stress pathway (PubMed:24035498)

More Common Targets

BACH2 | BAD | BAG1 | BAG2 | BAG3 | BAG4 | BAG5 | BAG6 | BAGE | BAGE2 | BAGE3 | BAGE4 | BAGE5 | BAHCC1 | BAHD1 | BAIAP2 | BAIAP2-DT | BAIAP2L1 | BAIAP2L2 | BAIAP3 | BAK1 | BALR6 | BAMBI | BANCR | BANF1 | BANF2 | BANK1 | BANP | BAP1 | BARD1 | BARHL1 | BARHL2 | BARX1 | BARX1-DT | BARX2 | BASC complex | BASP1 | BASP1-AS1 | BASP1P1 | BATF | BATF2 | BATF3 | BAX | BAZ1A | BAZ1A-AS1 | BAZ1B | BAZ2A | BAZ2B | BAZ2B-AS1 | BBC3 | BBIP1 | BBLN | BBOF1 | BBOX1 | BBOX1-AS1 | BBS1 | BBS10 | BBS12 | BBS2 | BBS4 | BBS5 | BBS7 | BBS9 | BBSome complex | BBX | BCAM | BCAN | BCAN-AS1 | BCAP29 | BCAP31 | BCAR1 | BCAR3 | BCAR3-AS1 | BCAR4 | BCAS1 | BCAS2 | BCAS2P2 | BCAS3 | BCAS4 | BCAT1 | BCAT2 | BCCIP | BCDIN3D | BCDIN3D-AS1 | BCHE | BCKDHA | BCKDHB | BCKDK | BCL10 | BCL10-AS1 | BCL11A | BCL11B | BCL2 | BCL2A1 | BCL2L1 | BCL2L10 | BCL2L11 | BCL2L12 | BCL2L13 | BCL2L14